Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Restructuring Costs (2020 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Restructuring Costs over the past 6 years, most recently at -$2.5 million for Q2 2025.

  • For Q2 2025, Restructuring Costs fell 441.33% year-over-year to -$2.5 million; the TTM value through May 2025 reached -$1.1 million, down 167.93%, while the annual FY2025 figure was -$1.7 million, 205.5% down from the prior year.
  • Restructuring Costs for Q2 2025 was -$2.5 million at Lifecore Biomedical, Inc. \De\, down from -$115000.0 in the prior quarter.
  • Over five years, Restructuring Costs peaked at $5.3 million in Q1 2022 and troughed at -$2.5 million in Q2 2025.
  • A 5-year average of $1.1 million and a median of $754500.0 in 2024 define the central range for Restructuring Costs.
  • Biggest five-year swings in Restructuring Costs: surged 9125.0% in 2024 and later plummeted 441.33% in 2025.
  • Year by year, Restructuring Costs stood at $627000.0 in 2021, then fell by 10.21% to $563000.0 in 2022, then tumbled by 72.11% to $157000.0 in 2023, then skyrocketed by 370.06% to $738000.0 in 2024, then plummeted by 441.33% to -$2.5 million in 2025.
  • Business Quant data shows Restructuring Costs for LFCR at -$2.5 million in Q2 2025, -$115000.0 in Q1 2025, and $738000.0 in Q2 2024.